Ronald G Victor MD
Director, Cedars-Sinai Center for Hypertension, Cedars-Sinai Heart Institute, Los Angeles, CA Associate Director, Clinical Research, Cedars-Sinai Heart Institute; Burns and Allen Chair in Cardiology Research, Cedars-Sinai Heart InstituteDr. Victor completed his undergraduate work at Cornell University in Ithaca, New York, and subsequently earned a medical degree from Tulane University School of Medicine in New Orleans, Louisiana. He completed his internship and residency in internal medicine at the University of California, Los Angeles, and a cardiology fellowship at Duke University in Durham, North Carolina. He also completed a special cardiovascular research fellowship at the University of Iowa and a visiting fellowship in clinical neurophysiology at the University of Uppsala in Uppsala, Sweden.
Dr. Victor is currently Director of the Cedars-Sinai Center for Hypertension at the Cedars-Sinai Medical Center in Los Angeles, California, Associate Director of Clinical Research at Cedars-Sinai, and the Burns and Allen Chair in Cardiology Research at the Cedars-Sinai Heart Institute.
Dr. Victor has been awarded numerous grants from the National Institutes of Health and other organizations for his studies in heart disease. His research focuses on the neural mechanisms of hypertension and hypertension in special populations. He is widely published and is on the board of several industry publications, including the American Journal of Hypertension. He is also active in many organizations, including the American Society of Hypertension.
Disclosures
Ronald G. Victor, MD serves as a consultant for Eli Lilly, Capricor, and Ironwood Pharmaceuticals.
Ronald G. Victor, MD has received research/grant support from Eli Lilly and Capricor.
Recent Contributions to PracticeUpdate:
- Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels
- Association Between Urinary Sodium and Potassium Excretion and Blood Pressure Among Adults
- All Hypertensive Disorders of Pregnancy Increase the Risk of Future Cardiovascular Disease
- The J-Curve Aligns With Different Systolic Blood Pressure Targets
- Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis
- Systolic Blood Pressure Reduction Lowers the Risk of Cardiovascular Disease and Mortality
- Chlorthalidone Elicits Favorable Initial Reduction in SBP
- High Visit-to-Visit Variability of Blood Pressure Is Predictive of Adverse Cardiovascular Events in Patients With Stable CHD
- Primary Aldosteronism in Primary Care Practice
- Risk Factors and Comorbidities Are Different in Young vs Old Hypertensive Patients